Tobias Millrood

Of Counsel

Tobias has over 25 years of complex litigation experience, with a focus on pharmaceutical and medical device litigation. 

He has served in numerous Court-appointed leadership positions in pharmaceutical and medical device litigations. Most recently, he was appointed by Hon. F. Dennis Saylor as Co-Lead Counsel in In re Zofran (Ondansetron) Products Liability Litigation, MDL 2657 and by Hon. Rebecca Pallmeyer as Co-Lead Counsel in In re Zimmer Nexgen Knee Products Liability Litigation, MDL 2272. 

Tobias was the first to file a hormone therapy lawsuit in the nation in 2002 and went on to dedicate the next twelve years to the litigation. He tried four hormone therapy cases, obtaining jury verdicts for the Plaintiffs in all four, including verdicts in November 2009 for $34.3 million and December 2011 for $72.6 million.  

Earlier in his career, Tobias garnered several notable achievements, including serving as co-counsel in a $22 million medical malpractice verdict in Wallace v. Fraider (Phila. CCP Mar. 2001), one of the highest in state history. 

Residing in Philadelphia, USA, Tobias is President of the American Association for Justice (AAJ) for 2020-21. He is a member of the Pennsylvania Association for Justice (PAJ) Board of Governors and the Philadelphia Trial Lawyers (PTLA) Board of Directors.  

PGMBM (a trading name of Excello Law Limited) – SRA License Number 512898

Excello Law is authorised and regulated by the Solicitors Regulation Authority and complies with the Solicitors Code of Conduct, a copy of which can be located here.